Immunotech Biopharm Ltd - ESG Rating & Company Profile powered by AI
This report of Immunotech Biopharm Ltd employs data points from across the web and also from available filings by Immunotech Biopharm Ltd. This article contains a questions and answers table about Immunotech Biopharm Ltd. This ESG score includes 17 United Nations SDGs including: 'Quality Education', 'Reduced Inequalities' and 'Peace, Justice & Strong Institutions'.
Immunotech Biopharm Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 1.6, social score of 1.6 and governance score of 4.0.
2.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1976 | Xiamen Amoytop Biotech Co Ltd | 2.5 | Medium |
| 1976 | Xiangxue Pharmaceutical Co Ltd | 2.5 | Medium |
| 2019 | Immunotech Biopharm Ltd | 2.4 | Medium |
| 2019 | Advanced Accelerator Applications SA | 2.4 | Medium |
| 2019 | Active Fine Chemicals Ltd | 2.4 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Immunotech Biopharm Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Immunotech Biopharm Ltd report the average age of the workforce?
Sign up for free to unlockDoes Immunotech Biopharm Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Immunotech Biopharm Ltd offer flexible work?
Sign up for free to unlockDoes Immunotech Biopharm Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Immunotech Biopharm Ltd conduct supply chain audits?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Immunotech Biopharm Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose water use targets?
Sign up for free to unlockDoes Immunotech Biopharm Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Immunotech Biopharm Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Immunotech Biopharm Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Immunotech Biopharm Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Immunotech Biopharm Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Immunotech Biopharm Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Immunotech Biopharm Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose its waste policy?
Sign up for free to unlockDoes Immunotech Biopharm Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose energy use targets?
Sign up for free to unlockDoes Immunotech Biopharm Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Immunotech Biopharm Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Immunotech Biopharm Ltd
These potential risks are based on the size, segment and geographies of the company.
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the prevention of postsurgical recurrence of liver cancer. The company is also conducting pre-clinical and clinical trial studies for EAL to treat lung cancer, glioma, gastric cancer, and colorectal cancer. Its products also include CAR-T cell series products for the treatment of hematologic cancer; and TCR-T cell series products for solid tumour treatment. The company was founded in 2006 and is headquartered in Beijing, the People's Republic of China.